Citation Impact
1 from Science/Nature 50 standout
Citing Papers
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Works of C. Decroisette being referenced
Randomized phase III study of nivolumab and ipilimumab versus carboplatin-based doublet in first-line treatment of PS 2 or elderly (≥ 70 years) patients with advanced non–small cell lung cancer (Energy-GFPC 06-2015 study).
2022
Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018
2020
Author Peers
| Author | PRM | Oncology | Surgery | Molecular Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| C. Decroisette | 513 | 481 | 101 | 127 | 48 | 688 | |
| W. Witschel | 1 | 2 | 37 | 56 | 643 | ||
| CM Harris | 200 | 20 | 15 | 339 | |||
| Simon Hebeisen | 15 | 9 | 5 | 341 | 19 | 533 | |
| Tate N. Trujillo | 12 | 13 | 52 | 49 | 11 | 394 | |
| Halil İbrahim Uçar | 41 | 11 | 86 | 28 | 27 | 277 |
All Works
Loading papers...